1. Home
  2. PBYI vs QH Comparison

PBYI vs QH Comparison

Compare PBYI & QH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • QH
  • Stock Information
  • Founded
  • PBYI 2010
  • QH 2012
  • Country
  • PBYI United States
  • QH China
  • Employees
  • PBYI N/A
  • QH N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • QH Business Services
  • Sector
  • PBYI Health Care
  • QH Consumer Discretionary
  • Exchange
  • PBYI Nasdaq
  • QH Nasdaq
  • Market Cap
  • PBYI 154.1M
  • QH 134.5M
  • IPO Year
  • PBYI N/A
  • QH 2020
  • Fundamental
  • Price
  • PBYI $3.14
  • QH $1.42
  • Analyst Decision
  • PBYI Strong Buy
  • QH
  • Analyst Count
  • PBYI 1
  • QH 0
  • Target Price
  • PBYI $7.00
  • QH N/A
  • AVG Volume (30 Days)
  • PBYI 418.2K
  • QH 14.2K
  • Earning Date
  • PBYI 05-01-2025
  • QH 04-07-2025
  • Dividend Yield
  • PBYI N/A
  • QH N/A
  • EPS Growth
  • PBYI 37.78
  • QH N/A
  • EPS
  • PBYI 0.62
  • QH N/A
  • Revenue
  • PBYI $230,468,000.00
  • QH $493,471,493.00
  • Revenue This Year
  • PBYI N/A
  • QH N/A
  • Revenue Next Year
  • PBYI $3.27
  • QH N/A
  • P/E Ratio
  • PBYI $5.06
  • QH N/A
  • Revenue Growth
  • PBYI N/A
  • QH N/A
  • 52 Week Low
  • PBYI $2.23
  • QH $0.25
  • 52 Week High
  • PBYI $6.06
  • QH $2.27
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 45.33
  • QH 43.09
  • Support Level
  • PBYI $3.14
  • QH $1.40
  • Resistance Level
  • PBYI $3.56
  • QH $1.54
  • Average True Range (ATR)
  • PBYI 0.19
  • QH 0.05
  • MACD
  • PBYI -0.05
  • QH -0.01
  • Stochastic Oscillator
  • PBYI 17.54
  • QH 14.21

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About QH Quhuo Limited American Depository Shares

Quhuo Ltd is a gig economy platform in China. The company provides tech-enabled, end-to-end operational solutions to consumer service businesses in industries with e-commerce exposure, including food delivery, ride-hailing, housekeeping, bike-sharing, and other services. The company generates revenue predominantly from service fees paid by its industry customers, and to a lesser extent, from rental fees under its car leasing agreements with drivers engaged in the ride-hailing solutions. It derives all of its revenue from the PRC. The company's revenues are categorized into On-demand delivery solutions; Mobility service solutions; Housekeeping solutions and other services. The On-demand delivery solutions generate key revenue for the firm.

Share on Social Networks: